A

Alexia F. Kalogeropulou

Foghorn Therapeutics (United States)

ORCID: 0000-0001-5185-7694

14 papers and 467 citations.

PubIndex Score80Top 20% · early-careerHow it's scored

🔥#8 Rising Star in Fungal and yeast genetics research

14Publications

467Total Citations

#8in Fungal and yeast genetics research

First publication: 2022

Top publicationsby citations

Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule binding

Alexia F. Kalogeropulou, Dario R. Alessi, Sven M. Lange et al.|Biochemical Journal|2022

Cited by 141

Impact of 100 LRRK2 variants linked to Parkinson’s Disease on kinase activity and microtubule binding

Alexia F. Kalogeropulou, Dario R. Alessi, Francesca Tonelli et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022

Cited by 8

Indexing the rest of 14 publications…